Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C22H28N2O2 |
| Molecular Weight | 352.4699 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CCC1=CC=CC=C1)NCC(O)C2=CC=C3NC(=O)CCC3=C2
InChI
InChIKey=YYUZPBGIBVJYSI-UHFFFAOYSA-N
InChI=1S/C22H28N2O2/c1-22(2,13-12-16-6-4-3-5-7-16)23-15-20(25)18-8-10-19-17(14-18)9-11-21(26)24-19/h3-8,10,14,20,23,25H,9,11-13,15H2,1-2H3,(H,24,26)
| Molecular Formula | C22H28N2O2 |
| Molecular Weight | 352.4699 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Simultaneous determination of (R)- and (S)-brefanolol in human plasma: high-performance liquid chromatographic assay on a chiral stationary phase. | 1994-03 |
|
| Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension. | 1990-07 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1696669
In a placebo-controlled, randomized, cross-over study, 16 patients (10 males, 6 females; 50.6 +/- 10.4 years; body weight of 74.5 +/- 8.9 kg; mean +/- SD) with arterial hypertension (WHO stages I and II) were administered single oral doses of placebo, 80 mg of propranolol, as well as 50 and 100 mg of brefanolol
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:01 GMT 2025
by
admin
on
Mon Mar 31 18:28:01 GMT 2025
|
| Record UNII |
DVO6SSG9S3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C72900
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
||
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DVO6SSG9S3
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
Brefonalol
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
C72653
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL1742432
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
5996
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
65880
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
104051-20-9
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
100000088659
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
DTXSID20869414
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY | |||
|
SUB05883MIG
Created by
admin on Mon Mar 31 18:28:01 GMT 2025 , Edited by admin on Mon Mar 31 18:28:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |